Table 2.

Practice patterns in older patients and rest of the source population.

	Older Patients (≥70 Years)	Rest of the Source Population (<70 Years)
Variable	N (% or Range)	N (% or Range)	p Value
Total number	57	125
Multi-agent chemotherapy	56 (98.2)	125 (100)	0.127
Chemotherapy regimen
mFFX	31 (54.4)	111 (88.8)	<0.001
GnP	24 (42.1)	14 (12.2)	<0.001
Gemcitabine/capecitabine	1 (1.8)	0 (0)	0.127
Gemcitabine	1 (1.8)	0 (0)	0.127
Median chemotherapy duration (months)	4 (2–18)	4 (1–15)	0.233
Surgical Exploration	43 (75.4)	111 (88.8)	0.025
Resected	38 (66.7)	86 (68.8)	0.775
Post-SBRT/surgery chemotherapy	19 (33.3)	45 (36.0)	0.726

Abbreviations: mFFX, modified FOLFIRINOX; GnP, gemcitabine plus nab-paclitaxel. Bold text indicates p-value < 0.05.